| Literature DB >> 34589221 |
Patrick Bettiol1, Alec Egan1, Cameron Cox1, Eric Wait1, George Brindley1.
Abstract
OBJECTIVES: Implant failure leading to revision total joint arthroplasty can occur through a variety of different mechanisms which are typically associated with a soft tissue response adjacent to the implant that provide insight into the underlying etiology of implant failure. The objective of this study was to elucidate mechanisms of implant failure as they relate to histological classification and findings of adjacent periprosthetic tissue.Entities:
Keywords: Orthopedics/rehabilitation/occupational therapy; pathology; periprosthetic pathology; revision hip arthroplasty; revision knee arthroplasty
Year: 2021 PMID: 34589221 PMCID: PMC8474343 DOI: 10.1177/20503121211047099
Source DB: PubMed Journal: SAGE Open Med ISSN: 2050-3121
Description of study sample.
| Variable | n (%)[ | |
|---|---|---|
| N | 99 | (100.0%) |
| Demographics | ||
| Median months post-op (IQR) | 73 months | (26–174 months) |
| Median age (IQR) | 64 years | (54–73 years) |
| Operation | ||
| Total Hip Arthoplasty (THA) | 39 | (39.4%) |
| Total Knee Arthoplasty (TKA) | 58 | (58.6%) |
| Total Shoulder Arthroplasty (TSA) | 2 | (2%) |
| Location | ||
| Left | 45 | (45.5%) |
| Right | 53 | (53.5%) |
| Both | 1 | (1%) |
| Histologic findings | ||
| Type I[ | 47 | (47.5%) |
| Type II[ | 7 | (7.1%) |
| Type III[ | 13 | (13.1%) |
| Type IV[ | 32 | (32.3%) |
| Modes of failure | ||
| Hardware/mechanical failure | 15 | (15.2%) |
| Septic | 13 | (13.1%) |
| Instability | 35 | (35.4%) |
| Loosening | 24 | (24.2%) |
| Other | 12 | (12.1%) |
IQR: interquartile range.
All data are n (%) unless otherwise specified.
Type I: Wear particle induced type: Anucleate protein debris, calcification, histiocytic infiltrate, fibrous tissue, foreign body, giant cell, histiocytes, hyperplasia, and macrophages with abundant cytoplasm (epithelioid cells).
Type II: Infectious type: Diptheroids, Enterococcus, granulation tissue (infection related), lymphocytic infiltrate without giant cell reaction, soft-tissue necrosis, and Staphylococcus epidermidis.
Type III: Combined Type 1 and 2.
Type IV: Indeterminant type.
Odds ratios for modes of failure given histology type classification.
| Odds ratio (95% confidence interval) | |||||
|---|---|---|---|---|---|
| Hardware/mechanical | Infection | Instability | Loosening | Other | |
| Type I[ | 1.26 (0.43–3.75) | 0.33 (0.09–1.28) | 1.17 (0.54–2.53) | 1.55 (0.63–3.82) | 0.55 (0.16–1.96) |
| Type II[ | 0.94 (0.11–8.22) | 5.84 (1.43–23.8) | 0.39 (0.05–3.26) | 0.25 (0.01–4.56) | 1.19 (0.13–10.6) |
| Type III[ | 1.53 (0.44–5.34) | 0.77 (0.16–3.74) | 0.39 (0.11–1.43) | 0.38 (0.83–1.77) | 1.40 (0.35–5.69) |
| Type IV[ | 0.18 (0.01–3.09) | 0.467 (0.06–3.86) | 1.16 (0.41–3.27) | 1.87 (0.64–5.47) | 1.12 (0.22–5.63) |
Type I: Wear particle induced type: Anucleate protein debris, calcification, histiocytic infiltrate, fibrous tissue, foreign body, giant cell, histiocytes, hyperplasia, and macrophages with abundant cytoplasm (epithelioid cells).
Type II: Infectious type: Diptheroids, Enterococcus, granulation tissue (infection related), lymphocytic infiltrate without giant cell reaction, soft-tissue necrosis, and Staphylococcus epidermidis.
Type III: Combined Type I and II.
Type IV: Indeterminant type.
p-value < 0.05.
Independent histological findings—regression analysis of categorized modes of failure.
| Correlation of histological
findings with modes of failure | ||||
|---|---|---|---|---|
| Unstandardized coefficients | Standardized coefficients | Significance | ||
| B | SE | Beta | p-value | |
| Hardware/mechanical | ||||
| Anucleate protein debris | 0.387 | 0.187 | 0.251 | 0.041 |
| Histiocytes | 0.512 | 0.227 | 0.238 | 0.027 |
| | 0.850 | 0.365 | 0.231 | 0.022 |
| Synovitis | −0.206 | 0.083 | −0.246 | 0.015 |
| Infection | ||||
| Enterococcus | 0.919 | 0.317 | 0.360 | 0.005 |
| Granulation tissue | 0.415 | 0.126 | 0.297 | 0.001 |
| Necrosis | 0.409 | 0.193 | 0.195 | 0.036 |
| Aseptic loosening | ||||
| Synovitis | 0.232 | 0.099 | 0.235 | 0.021 |
| Other | ||||
| Synovial cell hyperplasia | 0.500 | 0.249 | 0.199 | 0.048 |
SE: standard error.
p ⩽ 0.05 = significant correlation between histologic finding and mode of failure. Beta = strength of correlation (Beta = 1 for two identical sets of values). Negative values indicate significant inverse relationship.
Only significant correlations (p ⩽ 0.05) shown.
Independent histological findings—regression analysis of independent modes of failure.
| Correlation of histological
findings with modes of failure | ||||
|---|---|---|---|---|
| Unstandardized coefficients | Standardized coefficients | Significance | ||
| B | SE | Beta | p-value | |
| Arthrofibrosis | ||||
| Fibrous tissue | 0.159 | 0.060 | 0.309 | 0.009 |
| Macrophages with abundant cytoplasm | −0.264 | 0.095 | −0.386 | 0.007 |
| Crepitus | ||||
| Hyperplasia | 0.062 | 0.030 | 0.236 | 0.038 |
| Eccentric wear | ||||
| Fibrohistiocytic | 0.116 | 0.036 | 0.350 | 0.002 |
| Lymphocytes | 0.064 | 0.028 | 0.240 | 0.024 |
| Infection | ||||
| Enterococcus | 0.909 | 0.314 | 0.378 | 0.005 |
| Granulation tissue | 0.324 | 0.124 | 0.246 | 0.011 |
| Macrophages with abundant cytoplasm | −0.366 | 0.142 | −0.377 | 0.011 |
| Loosening | ||||
| Necrosis | 0.542 | 0.266 | 0.214 | 0.045 |
| Synovitis | 0.222 | 0.101 | 0.225 | 0.031 |
| Fibrohistiocytic | 0.472 | 0.153 | 0.327 | 0.003 |
| Malalignment | ||||
| Lymphocytes | 0.064 | 0.028 | 0.240 | 0.024 |
| Foreign body | −0.062 | 0.026 | −0.258 | 0.021 |
| Histiocytes | 0.361 | 0.053 | 0.620 | 0.000 |
| Pain | ||||
| Synovial cell layer | 0.522 | 0.251 | 0.208 | 0.041 |
| Periprosthetic fracture | ||||
| | 0.985 | 0.145 | 0.575 | 0.000 |
| Synovial cell layer | 0.215 | 0.087 | 0.247 | 0.016 |
| Reduced function | ||||
| Anucleate protein debris | 0.175 | 0.049 | 0.418 | 0.001 |
| Atrophic synovial lining | 0.500 | 0.052 | 0.703 | <0.001 |
| Wound dehiscence | ||||
| Calcification | 0.254 | 0.048 | 0.500 | 0.000 |
| Inflammation | 0.082 | 0.031 | 0.269 | 0.009 |
SE: standard error.
p ⩽ 0.05 = significant correlation between histologic and specific modes of failure. Beta = strength of correlation (Beta = 1 for two identical sets of values). Negative values indicate significant inverse relationship.
Only significant correlations (p ⩽ 0.05) shown.
Histological categories and all comorbidities—ANOVA regression analysis of independent modes of failure.
| Correlation of histological categories and all comorbidities with modes of failure | ||||
|---|---|---|---|---|
| R | Adjusted R2 | p-value | % of variance | |
| Eccentric wear | ||||
| Comorbidities | 0.694 | 0.322 | <0.001 | 32.2 |
| Infection | ||||
| Type II histology | 0.360 | 0.130 | <0.001 | 13.0 |
| Comorbidities | 0.598 | 0.161 | 0.028 | 16.1 |
| Malalignment | ||||
| Type III histology | 0.260 | 0.068 | 0.009 | 6.8 |
| Periprosthetic fracture | ||||
| Type II histology | 0.182 | 0.33 | <0.001 | 29.7 |
| Deteriorated bone | ||||
| Type IV histology | 0.239 | 0.057 | 0.017 | 5.7 |
| Pseudotumor | ||||
| Type IV histology | 0.239 | 0.057 | 0.017 | 5.7 |
| Comorbidities | 0.586 | 0.142 | 0.045 | 14.2 |
ANOVA: analysis of variance.
p ⩽ 0.05 = significant correlation between comorbidity, histology, and specific modes of failure.
R = strength of correlation (R = 1 for two identical sets of values). % Variance = percentage of variance in a mode of failure that can be accounted for by the given category of independent variables. (Example: Type 1 histology accounts for 11.2% of variance in failure by arthrofibrosis.)
This table only includes significant correlations (p ⩽ 0.05).
Independent comorbidities—regression analysis of categorized modes of failure.
| Correlation of independent comorbidities with modes of failure | ||||
|---|---|---|---|---|
| Unstandardized coefficients | Standardized coefficients | Significance | ||
| B | SE | Beta | p-value | |
| Hardware/mechanical | ||||
| Osteosarcoma | 0.846 | 0.392 | 0.230 | 0.034 |
| Septic | ||||
| Crohn’s | 0.949 | 0.415 | 0.264 | 0.025 |
| Deep venous thrombosis | 0.888 | 0.239 | 0.348 | <0.001 |
| Lung disease | 0.812 | 0.351 | 0.226 | 0.023 |
| Rheumatoid arthritis | 0.204 | 0.099 | 0.209 | 0.043 |
SE: standard error.
p ⩽ 0.05 = significant correlation between specific comorbidities and mode of failure. Beta = strength of correlation (Beta = 1 for two identical sets of values). Negative values indicate significant inverse relationship.
This table only includes significant correlations (p ⩽ 0.05).
Independent comorbidities—regression analysis of independent modes of failure.
| Correlation of independent
comorbidities with modes of failure | ||||
|---|---|---|---|---|
| Unstandardized coefficients | Standardized coefficients | Significance | ||
| B | SE | Beta | p-value | |
| Crepitus | ||||
| Anemia | 0.200 | 0.048 | 0.477 | <0.001 |
| Deteriorated bone | ||||
| Rheumatoid arthritis | 0.077 | 0.033 | 0.282 | 0.024 |
| Hardware failure | ||||
| Arthritis | 0.219 | 0.081 | 0.315 | 0.008 |
| Osteosarcoma | 0.934 | 0.212 | 0.426 | <0.001 |
| Infection | ||||
| Crohn’s | 0.925 | 0.391 | 0.274 | 0.021 |
| Deep venous thrombosis | 0.905 | 0.226 | 0.377 | <0.001 |
| Lung disease | 0.823 | 0.331 | 0.244 | 0.015 |
| Pain | ||||
| Anemia | −0.463 | 0.232 | −0.224 | 0.049 |
| Pseudotumor | ||||
| Breast cancer | 0.343 | 0.056 | 0.589 | <0.001 |
SE: standard error.
p ⩽ 0.05 = significant correlation between comorbidity and specific modes of failure. Beta = strength of correlation (Beta = 1 for two identical sets of values). Negative values indicate significant inverse relationship.
Only significant correlations (p ⩽ 0.05) shown.